IFPMA revamps code of conduct to "do the right thing" in industry
This article was originally published in SRA
Executive Summary
The IFPMA, which represents the global pharmaceutical industry, particularly in its dealings with UN bodies such as the World Health Organisation, has updated its code of conduct to take account of changes to national industry codes and issues relating to ethical and professional standards around the world1,2. The association says the revamped code, when it comes into effect in September, will provide an "effective framework for ethical business practices".